• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较通过慢性心力衰竭患者的理赔数据来衡量药物依从性的不同策略。

Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.

机构信息

PMV research group, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Department of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Berlin, Germany.

出版信息

Clin Pharmacol Ther. 2019 Jul;106(1):211-218. doi: 10.1002/cpt.1378. Epub 2019 Mar 12.

DOI:10.1002/cpt.1378
PMID:30697693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6617982/
Abstract

Medication adherence correlates with morbidity and mortality in patients with chronic heart failure (CHF), but is difficult to assess. We conducted a retrospective methodological cohort study in 3,808 CHF patients, calculating adherence as proportion of days covered (PDC) utilizing claims data from 2010 to 2015. We aimed to compare different parameters' influence on the PDC of elderly CHF patients exemplifying a complex chronic disease. Investigated parameters were the assumed prescribed daily dose (PDD), stockpiling, and periods of hospital stay. Thereby, we investigated a new approach using the PDD assigned to different percentiles. The different dose assumptions had the biggest influence on the PDC, with variations from 41.9% to 83.7%. Stockpiling and hospital stays increased the values slightly. These results queries that a reliable PDC can be calculated with an assumed PDD. Hence, results based on an assumed PDD have to be interpreted carefully and should be presented with sensitivity analyses to show the PDC's possible range.

摘要

药物依从性与慢性心力衰竭(CHF)患者的发病率和死亡率相关,但难以评估。我们对 3808 例 CHF 患者进行了回顾性方法学队列研究,利用 2010 年至 2015 年的索赔数据,计算了药物覆盖率(PDC)作为比例的天数。我们旨在比较不同参数对老年 CHF 患者 PDC 的影响,以说明一种复杂的慢性病。研究的参数是假定的每日剂量(PDD)、囤药和住院时间。因此,我们使用分配给不同百分位数的 PDD 研究了一种新方法。不同的剂量假设对 PDC 的影响最大,从 41.9%到 83.7%不等。囤药和住院时间略微增加了这些值。这些结果表明,一个可靠的 PDC 可以通过假定的 PDD 计算出来。因此,基于假定 PDD 的结果必须谨慎解释,并应进行敏感性分析,以显示 PDC 的可能范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/504f/6617982/4a0b4612685c/CPT-106-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/504f/6617982/8fe075c2547a/CPT-106-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/504f/6617982/4a0b4612685c/CPT-106-211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/504f/6617982/8fe075c2547a/CPT-106-211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/504f/6617982/4a0b4612685c/CPT-106-211-g002.jpg

相似文献

1
Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure.比较通过慢性心力衰竭患者的理赔数据来衡量药物依从性的不同策略。
Clin Pharmacol Ther. 2019 Jul;106(1):211-218. doi: 10.1002/cpt.1378. Epub 2019 Mar 12.
2
Association Between Medication Adherence and the Outcomes of Heart Failure.药物依从性与心力衰竭结局的关系。
Pharmacotherapy. 2018 May;38(5):539-545. doi: 10.1002/phar.2107. Epub 2018 Apr 30.
3
Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure.老年心力衰竭住院患者出院后心血管药物治疗依从性的时间趋势。
Clin Pharmacol Ther. 2010 Oct;88(4):548-54. doi: 10.1038/clpt.2010.139. Epub 2010 Sep 8.
4
In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.使用索赔数据分析心力衰竭患者药物依从性的标准:系统评价。
Heart Fail Rev. 2018 Jan;23(1):63-71. doi: 10.1007/s10741-017-9656-x.
5
Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.充血性心力衰竭医疗补助受益人的药物治疗使用情况及依从性
Clin Ther. 2007 Aug;29(8):1771-83. doi: 10.1016/j.clinthera.2007.08.015.
6
Variation in medication adherence in heart failure.心力衰竭患者药物依从性的差异。
JAMA Intern Med. 2013 Mar 25;173(6):468-70. doi: 10.1001/jamainternmed.2013.2509.
7
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.良好依从性与不良依从性:使用行政索赔数据进行依从性测量的最佳切点
Curr Med Res Opin. 2009 Sep;25(9):2303-10. doi: 10.1185/03007990903126833.
8
Comparison of a new 3-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.比较一种新的 3 项自我报告药物依从性测量方法与患有心脏代谢疾病患者的药房数据。
Am Heart J. 2020 Oct;228:36-43. doi: 10.1016/j.ahj.2020.06.012. Epub 2020 Jun 24.
9
Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data.利用电子药房报销数据中的供应天数值来评估骨质疏松症药物治疗的依从性被低估了。
Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):67-74. doi: 10.1002/pds.3718. Epub 2014 Oct 21.
10
Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.2型糖尿病初治老年患者中与基础胰岛素治疗方案依从性和持续性相关的特征:预填充笔式注射器与小瓶/注射器的比较
Adv Ther. 2015 Dec;32(12):1206-21. doi: 10.1007/s12325-015-0266-5. Epub 2015 Nov 13.

引用本文的文献

1
Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.评估经济激励措施作为提高2型糖尿病患者药物依从性的工具:一项系统评价和荟萃分析。
Diabetes Ther. 2025 Mar;16(3):527-545. doi: 10.1007/s13300-025-01694-y. Epub 2025 Feb 10.
2
Adherence to Pharmacotherapies After Heart Transplantation in Relation to Multimorbidity and Socioeconomic Position: A Nationwide Register-Based Study.心脏移植后药物治疗依从性与多种合并症和社会经济地位的关系:一项全国范围内基于登记的研究。
Transpl Int. 2023 Oct 11;36:11676. doi: 10.3389/ti.2023.11676. eCollection 2023.
3

本文引用的文献

1
Adherence to chronic medication in older populations: application of a common protocol among three European cohorts.老年人群对慢性药物的依从性:欧洲三个队列中通用方案的应用。
Patient Prefer Adherence. 2018 Oct 5;12:1975-1987. doi: 10.2147/PPA.S164819. eCollection 2018.
2
Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database.一种利用澳大利亚药品福利计划(PBS)数据库中的再填充数据计算多药治疗依从性的新方法的实施与验证。
Clin Epidemiol. 2018 Sep 6;10:1181-1194. doi: 10.2147/CLEP.S153496. eCollection 2018.
3
Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
心力衰竭患者药物治疗的依从性和持久性:一项全国性队列研究,2014-2020 年。
ESC Heart Fail. 2023 Feb;10(1):405-415. doi: 10.1002/ehf2.14206. Epub 2022 Oct 20.
4
A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation.预测模型:评估住院房颤患者不持续或不遵从直接口服抗凝药物治疗的情况。
J Manag Care Spec Pharm. 2022 Oct;28(10):1161-1172. doi: 10.18553/jmcp.2022.28.10.1161.
5
Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS.关于改善心血管药物依从性中覆盖天数比例方法报告的研究:一项范围综述及新工具TEN-SPIDERS
Br J Clin Pharmacol. 2022 Oct;88(10):4427-4442. doi: 10.1111/bcp.15391. Epub 2022 May 22.
6
Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors.确定抗抑郁药、双膦酸盐和他汀类药物的依从性时间模式以及相关的患者因素。
SSM Popul Health. 2021 Nov 19;17:100973. doi: 10.1016/j.ssmph.2021.100973. eCollection 2022 Mar.
7
Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants - A Retrospective Cohort Study in Health Insurance Claims Data.直接口服抗凝剂有效治疗的最低必要依从性估计阈值——基于健康保险理赔数据的回顾性队列研究
Patient Prefer Adherence. 2021 Sep 24;15:2209-2220. doi: 10.2147/PPA.S324315. eCollection 2021.
8
Comparing the Sensitivities of Measures of Adherence to Antihypertensive Drugs Using Korean National Health Insurance Claims Data.利用韩国国民健康保险理赔数据比较抗高血压药物依从性测量指标的敏感性
Patient Prefer Adherence. 2021 Aug 8;15:1717-1728. doi: 10.2147/PPA.S322745. eCollection 2021.
9
Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case-control studies.德国养老院居民口服抗凝药物相互作用:基于两项巢式病例对照研究的维生素 K 拮抗剂与非维生素 K 拮抗剂口服抗凝药物比较。
Clin Res Cardiol. 2020 Apr;109(4):465-475. doi: 10.1007/s00392-019-01526-7. Epub 2019 Jul 8.
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
一种远程提供的量身定制的多组分方法对高脂血症、高血压和糖尿病患者加强服药依从性的影响:STIC2IT 整群随机临床试验
JAMA Intern Med. 2018 Sep 1;178(9):1182-1189. doi: 10.1001/jamainternmed.2018.3189.
4
Patterns of statin use and long-term adherence and persistence among older adults with diabetes.老年人糖尿病患者中他汀类药物的使用模式及长期依从性和持续性。
J Diabetes. 2018 Sep;10(9):699-707. doi: 10.1111/1753-0407.12769. Epub 2018 May 10.
5
Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.谁从固定剂量复方制剂中获益?联合应用氨氯地平/阿托伐他汀治疗起始者的他汀类药物 2 年依从性轨迹。
Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1465-1473. doi: 10.1002/pds.4342. Epub 2017 Oct 25.
6
In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.使用索赔数据分析心力衰竭患者药物依从性的标准:系统评价。
Heart Fail Rev. 2018 Jan;23(1):63-71. doi: 10.1007/s10741-017-9656-x.
7
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.医生的指南遵循与射血分数降低的心力衰竭门诊患者的更好预后相关:QUALIFY 国际注册研究。
Eur J Heart Fail. 2017 Nov;19(11):1414-1423. doi: 10.1002/ejhf.887. Epub 2017 Apr 30.
8
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
9
Measuring medication adherence in patients with incident hypertension: a retrospective cohort study.测量初发性高血压患者的药物依从性:一项回顾性队列研究。
BMC Health Serv Res. 2017 Feb 13;17(1):135. doi: 10.1186/s12913-017-2073-y.
10
Long-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort study.西澳大利亚州心力衰竭二级预防药物的长期使用:一项基于人群队列研究的方案
BMJ Open. 2016 Nov 1;6(11):e014397. doi: 10.1136/bmjopen-2016-014397.